Mesenchymal Stem Cells as Cellular Immunotherapeutics in Allogeneic Hematopoietic Stem Cell Transplantation

作者: Daniela Topolar , Barbara Götz , Stefan Schönberger , Dagmar Dilloo , Claudia Papewalis

DOI: 10.1007/10_2012_158

关键词:

摘要: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment option in disorders, immunodeficiencies and leukemia. To date graft-versus-host disease (GvHD) represents life-threatening complication even if associated with beneficial antileukemic reactivity. GvHD the clinical manifestation of donor cells reacting against host tissue. Because their ability to facilitate endogenous repair attenuate inflammation, MSC have evolved as highly attractive cellular therapeutic allo-HSCT. Here we report on experience use enhance engraftment prevent treat acute chronic GvHD. In early trials, shown considerable benefit setting manifest These encouraging results warrant further exploration.

参考文章(141)
Alexandra H Filipovich, Daniel Weisdorf, Steven Pavletic, Gerard Socie, John R Wingard, Stephanie J Lee, Paul Martin, Jason Chien, Donna Przepiorka, Daniel Couriel, Edward W Cowen, Patricia Dinndorf, Ann Farrell, Robert Hartzman, Jean Henslee-Downey, David Jacobsohn, George McDonald, Barbara Mittleman, J Douglas Rizzo, Michael Robinson, Mark Schubert, Kirk Schultz, Howard Shulman, Maria Turner, Georgia Vogelsang, Mary ED Flowers, National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report Biology of Blood and Marrow Transplantation. ,vol. 21, pp. 945- 956 ,(2005) , 10.1016/J.BBMT.2014.12.001
Alexandra H. Filipovich, Daniel Weisdorf, Steven Pavletic, Gerard Socie, John R. Wingard, Stephanie J. Lee, Paul Martin, Jason Chien, Donna Przepiorka, Daniel Couriel, Edward W. Cowen, Patricia Dinndorf, Ann Farrell, Robert Hartzman, Jean Henslee-Downey, David Jacobsohn, George McDonald, Barbara Mittleman, J. Douglas Rizzo, Michael Robinson, Mark Schubert, Kirk Schultz, Howard Shulman, Maria Turner, Georgia Vogelsang, Mary E.D. Flowers, National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report Biology of Blood and Marrow Transplantation. ,vol. 11, pp. 945- 956 ,(2005) , 10.1016/J.BBMT.2005.09.004
Michael L. Dustin, Role of adhesion molecules in activation signaling in T lymphocytes. Journal of Clinical Immunology. ,vol. 21, pp. 258- 263 ,(2001) , 10.1023/A:1010927208180
Przepiorka D, Weisdorf D, Hows J, Beatty P, Martin P, Klingemann Hg, Thomas Ed, 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplantation. ,vol. 15, pp. 825- 828 ,(1995)
D Weisdorf, R Haake, B Blazar, W Miller, P McGlave, N Ramsay, J Kersey, A Filipovich, Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood. ,vol. 75, pp. 1024- 1030 ,(1990) , 10.1182/BLOOD.V75.4.1024.1024
Cristina Sancricca, Mesenchymal stem cells: Molecular characteristics and clinical applications World Journal of Stem Cells. ,vol. 2, pp. 67- 80 ,(2010) , 10.4252/WJSC.V2.I4.67
Muriel Sudres, Françoise Norol, Aurélie Trenado, Sylvie Grégoire, Frédéric Charlotte, Béatrice Levacher, Jean-Jacques Lataillade, Philippe Bourin, Xavier Holy, Jean-Paul Vernant, David Klatzmann, José L. Cohen, Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice Journal of Immunology. ,vol. 176, pp. 7761- 7767 ,(2006) , 10.4049/JIMMUNOL.176.12.7761
Cynthia R Giver, Edmund K Waller, Mojtaba Akhtari, Mohammad S Hossain, Jian-Ming Li, Ying Lu, Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation Immunotherapy. ,vol. 1, pp. 599- 621 ,(2009) , 10.2217/IMT.09.32